Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Blend Labs, Inc. Director's Dealing 2022

Nov 18, 2022

32251_dirs_2022-11-18_2c0f11ef-e000-4501-8f05-1c07bce3fb23.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Blend Labs, Inc. (BLND)
CIK: 0001855747
Period of Report: 2022-11-16

Reporting Person: Sumner Crystal (Head of Legal, Compliance,Risk)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-11-16 Class A Common Stock M 12920 $0.87 Acquired 612692 Direct
2022-11-16 Class A Common Stock S 12920 $2.0379 Disposed 599772 Direct
2022-11-17 Class A Common Stock M 12920 $0.87 Acquired 612692 Direct
2022-11-17 Class A Common Stock S 12920 $1.9201 Disposed 599772 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-11-16 Stock Option (right to buy) $0.87 M 12920 Disposed 2028-12-16 Class A Common Stock (12920) Direct
2022-11-17 Stock Option (right to buy) $0.87 M 12920 Disposed 2028-12-16 Class A Common Stock (12920) Direct

Footnotes

F1: Certain of these shares are represented by previously reported restricted stock units.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3: This sale price represents the weighted average sale price of the shares sold ranging from $1.98 to $2.13 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F4: This sale price represents the weighted average sale price of the shares sold ranging from $1.88 to $1.955 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F5: The shares subject to this option are fully vested and immediately exercisable.